alexa Abstract | Molecular Docking Studies of Isorhamnetin from Corchorus olitorius with Target Alpha-amylase Related to Type 2 Diabetes

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


Type II diabetes (T2DM) is a metabolic disorder arising from impaired insulin action and insulin secretion, which leads to hyperglycemia and also the decimation of the body system. Acarbose, an anti-diabetic drug decreases the postprandial hyperglycemia, by slowing down the absorption of glucose through the inhibition of the carbohydratehydrolyzing enzyme (α–amylase), howbeit with serious side effects. In the present study, with the aid of in silico experiment we have identified isorhamnetin from Corchorus olitorius plant to have a higher inhibitory potential on alpha-amylase (-8.5Kcal/mol) as compared with acarbose (-7.1Kcal/mol) and other compounds (caffeic acid, -6.5 Kcal/mol and chlorogenic acid, -7.3 Kcal/mol) characterized from the same plant (Corchorus olitorius). This study however corroborates the earlier wet experiment on the inhibitory properties of isorhamnetin.

To read the full article Peer-reviewed Article PDF image

Author(s): DS Metibemu JA Saliu AO Metibemu OJ Oluwadahunsi G Oboh IO Omotuyi and OA Akinloye


Type II diabetes, Acarbose, Isorhamnetin, Chlorogenic acid, caffeic acid and in silico, Molecular Docking

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us